Sechenov School
Home › Pharmacology › Volume of Distribution

Volume of Distribution

apparent volume of distribution

For medical students2 min readUpdated 2026-10-10

The apparent volume of distribution ($V_d$) is a crucial hypothetical parameter in pharmacokinetics. It represents the fluid volume that would be required to uniformly dissolve the total amount of a drug in the body to achieve a concentration equal to that found in blood plasma. This metric helps clinicians understand where a drug concentrates: whether it remains exclusively in the bloodstream, penetrates the extracellular space, or actively accumulates inside cells.

Core FormulaVd = D / C0 (administered dose divided by initial plasma concentration)
Small VdAbout 3 liters (drug is localized primarily within the vascular compartment)
Medium VdAbout 15 liters (sum of plasma and extracellular fluid volumes)
Large Vd40–46 liters (corresponds to total body water in an average adult)
Abnormal ValuesUltra-high Vd indicates extensive tissue sequestration and peripheral binding

Definition and Mathematical Significance

It is important to understand that the volume of distribution is not a real anatomical fluid compartment in the human body, but rather a purely mathematical model. The more actively drug molecules leave the bloodstream and enter tissues, the lower their plasma concentration will be, and consequently, the higher the calculated $V_d$ will appear.

Within a single-compartment pharmacokinetic model, the basic formula is: $$V_d = \frac{Q}{C_p}$$ Where $Q$ represents the total amount of the drug in the body, and $C_p$ is its current plasma concentration.

If a drug is administered intravenously, the dose ($D$) is assumed to distribute instantaneously. In this case, the calculation uses the initial concentration ($C_0$) measured immediately after administration: $V_d = \frac{D}{C_0}$.

Compartment Classification

Depending on the value of $V_d$, one can predict which biological barriers a drug is capable of crossing:

Clinical Significance

Understanding a drug's distribution determines its clinical efficacy. For instance, drugs with a medium $V_d$ that fail to enter cells will be ineffective in treating intracellular infections. Furthermore, they do not cross the blood-brain barrier (BBB), making them useless for bacterial meningitis.

Medical practice requires special attention for drugs with ultra-high $V_d$ values that greatly exceed real physiological fluid volumes in humans. Such substances include:

Such figures indicate that the drug barely lingers in the blood, but is extensively sequestered in peripheral tissues. This is critically important in toxicology: during overdoses with such medications, hemodialysis is completely ineffective because cleaning the blood is pointless when the vast majority of the toxin is hidden inside organs.

Factors Affecting Distribution

The $V_d$ value is not a strict constant and can vary. The final value in a given patient is influenced by:

Frequently asked questions

Which drug groups have a small volume of distribution (approx. 3 L)?

A small volume of distribution (approx. 3 L), corresponding to average plasma volume, is characteristic of high-molecular-weight compounds.

They are localized primarily within the vascular system and do not cross the vascular endothelium or enter blood cells. An example is heparin, which has a volume of distribution of approximately 3.6 L.

Which drugs are characterized by an ultra-high volume of distribution that far exceeds body fluid volumes?

An ultra-high volume of distribution, significantly exceeding real body fluid volumes, is characteristic of drugs that sequester into peripheral tissues.

Such medications include:

  • Digoxin — volume of distribution of approx. 500 L.
  • Tricyclic antidepressants — imipramine and amitriptyline (approx. 1,050–1,600 L).
  • Chloroquine — volume of distribution of approx. 13,000 L.
What physiological and pathological factors can alter a drug's volume of distribution in a patient?

A drug's volume of distribution can be altered by various physiological factors and age-related changes.

This parameter is influenced by:

  • Sex and age — determine drug distribution patterns.
  • Body composition — the ratio of adipose tissue to body water.
  • Protein binding — decreased plasma albumin levels (e.g., in elderly patients) lead to changes in free fraction and apparent volume of distribution.
How is the volume of distribution used to calculate drug doses in clinical practice?

The volume of distribution is used in clinical practice to calculate the loading dose of a drug.

A loading dose is administered initially to rapidly fill the volume of distribution and achieve the target steady-state concentration. It is calculated using the formula: $D_H = V_d \cdot C_{ss}$ where $D_H$ is the loading dose, $V_d$ is the volume of distribution, and $C_{ss}$ is the desired steady-state concentration. The basic formula $V_d = D / C_0$ also relates the administered dose to the initial concentration.

What physicochemical properties of a drug molecule restrict its distribution exclusively to the vascular compartment?

Restriction of a drug exclusively to the vascular compartment is due to high molecular weight and inability to cross the vascular endothelium. Such compounds also fail to enter blood cells, keeping the substance primarily within the vascular space, mainly in blood plasma.

What does it mean if the calculated Vd exceeds the total volume of all body fluids?

This indicates pronounced sequestration (tissue binding) of the drug in peripheral tissues. As a result, the concentration of the substance directly in the blood plasma remains extremely low.

Can a patient be saved with hemodialysis in a chloroquine overdose?

No, hemodialysis is ineffective. Chloroquine has a massive apparent volume of distribution (approx. 13,000 liters), meaning it is localized predominantly in deep tissues rather than circulating blood.

Why are aminoglycosides not used to treat bacterial meningitis?

Aminoglycosides have a medium volume of distribution. Being hydrophilic compounds, they cannot cross cell membranes, and therefore fail to penetrate the blood-brain barrier.

Go deeper

More topics in Pharmacology

Opioid Receptor AntagonistsNeuraminidase InhibitorsNatural PenicillinsLeflunomide: Mechanism, Pharmacology, and UsesPlatelet Phosphodiesterase InhibitorsNitrofurans: Mechanism, Spectrum and Clinical UseIpratropium Bromide and Tiotropium BromideBeta-Blockers with Intrinsic Sympathomimetic ActivityChronic Obstructive Pulmonary DiseaseAntidiarrheal DrugsAntihypertensive DrugsVasopeptidase InhibitorsPharmacology →